Ueken, Switzerland

Roland Meier

This inventor holds 8 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Hoffmann-La Roche Inc., Genentech, Inc.. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Meier. Retrieved from https://idiyas.com/inventor/roland-meier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Basel, CH (2020 - 2021)
  • Ueken, CH (2011 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Roland Meier, Pharmaceutical Chemistry Inventor

Introduction

Roland Meier is an inventor associated with Ueken, Switzerland. His patent work includes methods for synthesizing complex pharmaceutical compounds, and he is credited with 8 patents.

Latest Patents

One of Meier’s latest patents, “Synthesis of quinazoline compounds,” describes methods for preparing quinazoline compounds that contain at least one atropisomeric center.

Another, “Forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making,” concerns a process for preparing a pyrido[1,2-a]pyrimidin-4-one derivative identified as useful as a pharmaceutically active compound.

Career Highlights

Meier’s listed company affiliations include Hoffmann-La Roche Inc. and Genentech, Inc. His patent work reflects a focus on synthetic methods and compounds relevant to pharmaceutical research.

Collaborations

Among Meier’s named coworkers are Olaf Grassmann and Nicholas Andrew White.

Conclusion

Roland Meier’s patent portfolio highlights his contributions to pharmaceutical chemistry, particularly the synthesis and preparation of potentially active compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…